Ghana: Rejects US Health Compact Over Medical Records Demands

• Ghana's Cabinet rejected a proposed US health compact due to "humiliating" provisions, according to President John Dramani Mahama.
• Key concerns included demands for Ghana's pathogen profile and medical records, and an exemption for supplied medical products from FDA inspection.
• The compact was intended to replace previous USAID health funding, following a restructuring of US foreign assistance.
• President Mahama linked the rejection to Ghana's Accra Reset initiative, advocating for greater health sovereignty and reduced reliance on external funding.
• The decision underscores Ghana's commitment to national data sovereignty and regulatory control in international agreements.

The rejection sets a precedent for Ghana's approach to international agreements, particularly concerning data sovereignty and regulatory control.

Ghana has firmly rejected a proposed health compact from the United States, with President John Dramani Mahama characterizing the agreement as "humiliating." The decision, made by Ghana's Cabinet, stemmed from significant concerns over several provisions, particularly those related to the sharing of sensitive health data, financial commitments, and the regulatory oversight of the nation's Food and Drugs Authority (FDA). This rejection underscores Ghana's commitment to safeguarding its national interests in international partnerships.

Speaking at the Council on Foreign Relations in New York on Friday, September 25, President Mahama detailed the reasons behind the swift dismissal of the compact. He explained that the Ministry of Health had initially reviewed the document before presenting it to Cabinet, where multiple clauses were identified as unacceptable. The proposed compact was intended to replace a portion of the health funding previously channeled through the United States Agency for International Development (USAID), marking a shift in the structure of US foreign assistance to Ghana.

Among the most contentious stipulations, according to President Mahama, was a demand for Ghana to provide the United States with its pathogen profile and national medical records. He questioned the rationale behind such a requirement, emphasizing the unprecedented nature of one country requesting another's medical data. The Cabinet's decision to reject the compact was made with unusual speed, a testament to the profound objections raised by its contents. The Minister of Health was subsequently tasked with formally communicating Ghana's decision to the US Ambassador.

The core of Ghana's objections centered on critical issues of national sovereignty, particularly concerning medical data and regulatory autonomy. The compact's provision requiring Ghana to furnish its pathogen profile and individual medical records to the United States was a primary point of contention, raising significant questions about Ghana medical data sovereignty. This demand was viewed as an unacceptable intrusion into the nation's health information systems and privacy.

Furthermore, the proposed agreement included a clause that would have exempted medicines and other medical products supplied under the program from inspection by Ghana’s FDA. This provision directly challenged the authority of Ghana's primary regulatory body, effectively bypassing local quality control and safety standards. Such an exemption would have undermined the Ghana FDA inspection exemption, potentially exposing the population to unverified medical supplies and setting a dangerous precedent for international health collaborations.

Beyond data and regulatory oversight, the compact also mandated Ghana to commit a specified amount of counterpart funding. While financial contributions are common in international agreements, the combination of this requirement with the other intrusive and sovereignty-eroding provisions contributed to the Cabinet's unanimous and rapid rejection of the proposal. The cumulative effect of these clauses was deemed to be profoundly detrimental to Ghana's national interests and dignity.

President Mahama has framed Ghana's rejection of the US health compact as a pivotal moment, linking it to the broader Accra Reset initiative and a renewed push for greater health sovereignty. He argued that the recent restructuring and withdrawal of US foreign assistance, which necessitated the proposed compact, starkly exposed the vulnerabilities of health systems heavily reliant on external funding. This experience has reinforced the need for nations in the Global South to build more resilient and self-sufficient health infrastructures.

In line with this vision, President Mahama launched "A Sovereign Future for Health" report at a separate Accra Reset event in New York. This comprehensive document outlines recommendations aimed at strengthening health systems across the Global South and reducing their dependence on foreign aid. The objective is not to isolate Ghana from its international partners but rather to foster more equitable and sustainable partnerships. This includes significant investment in local production of medicines and vaccines, enhancing research capabilities, and bolstering overall health systems.

Ghana's firm stance on the Mahama Ghana US health compact is not an isolated incident; reports indicate that other African countries have also voiced concerns regarding aspects of the new arrangements for US health funding Ghana. This collective apprehension highlights a growing desire among nations to assert greater control over their health policies and data, ensuring that international agreements respect national sovereignty and regulatory frameworks. The rejection sets a precedent for Ghana's approach to international agreements, particularly concerning data sovereignty and regulatory control.

This rejection sets a precedent for Ghana's approach to international agreements, particularly concerning data sovereignty and regulatory control. Lawyers and compliance officers advising on health sector investments or data sharing in Ghana should note the government's firm stance against provisions that bypass local regulatory authority or demand sensitive national medical data.

Source: Original reporting via Myjoyonline.com.